tiprankstipranks
IntelGenx Technologies (DE:0IL)
BERLIN:0IL

IntelGenx Technologies (0IL) Stock Price & Analysis

2 Followers

0IL Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€0.06 - €0.19
Previous Close€0.16
Volume32.26K
Average Volume (3M)14.80K
Market Cap
€29.71M
Enterprise Value€42.14M
Total Cash (Recent Filing)$2.08M
Total Debt (Recent Filing)$15.54M
Price to Earnings (P/E)N/A
Beta2.06
May 09, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding174,658,096
10 Day Avg. Volume0
30 Day Avg. Volume14,802
Standard Deviation0.02
R-Squared0.00
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)-2.83
Price to Sales (P/S)32.39
Price to Cash Flow (P/CF)-5.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue68.75
Enterprise Value/Gross Profit44.36
Enterprise Value/Ebitda-6.10
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%0.00%<0.01%100.00%
0.00%
Insiders
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors

0IL FAQ

What was IntelGenx Technologies’s price range in the past 12 months?
IntelGenx Technologies lowest stock price was €0.06 and its highest was €0.19 in the past 12 months.
    What is IntelGenx Technologies’s market cap?
    Currently, no data Available
    When is IntelGenx Technologies’s upcoming earnings report date?
    IntelGenx Technologies’s upcoming earnings report date is May 09, 2024 which is in 42 days.
      How were IntelGenx Technologies’s earnings last quarter?
      IntelGenx Technologies released its earnings results on Mar 21, 2024. The company reported -€0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.007.
        Is IntelGenx Technologies overvalued?
        According to Wall Street analysts IntelGenx Technologies’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does IntelGenx Technologies pay dividends?
          IntelGenx Technologies does not currently pay dividends.
          What is IntelGenx Technologies’s EPS estimate?
          IntelGenx Technologies’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does IntelGenx Technologies have?
          Currently, no data Available
          What happened to IntelGenx Technologies’s price movement after its last earnings report?
          IntelGenx Technologies reported an EPS of -€0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
            Which hedge fund is a major shareholder of IntelGenx Technologies?
            Currently, no hedge funds are holding shares in DE:0IL
            ---

            IntelGenx Technologies Stock Smart Score

            N/A
            Not Ranked
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Technicals

            SMA
            Positive
            20 days / 200 days
            Momentum
            3.37%
            12-Months-Change

            Fundamentals

            Return on Equity
            Trailing 12-Months
            Asset Growth
            -9.88%
            Trailing 12-Months

            Company Description

            IntelGenx Technologies

            IntelGenx Technologies Corp. is a oral drug delivery company, which focuses on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilm technology platform. Its products include rizaport, tadalafil, loxapine, and montelukast. The company also offers a comprehensive portfolio of pharmaceutical services, such as pharmaceutical research & development, clinical monitoring, regulatory support, tech transfer & manufacturing scale-up and commercial manufacturing. IntelGenx Technologies was founded on July 27, 1999 and is headquartered in Ville Saint-Laurent, Canada.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Aptose Biosciences
            Sintx Technologies
            Oncolytics Biotech
            IntelGenx Technologies
            Eton Pharmaceuticals
            Popular Stocks
            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis